SYDNEY: Australian medicinal cannabis company Little Green Pharma Ltd (ASX: LGP) has entered into a binding agreement to acquire 100% of rival Cannatrek Ltd via a scheme of arrangement, the companies announced on Wednesday. The all-scrip transaction will see Cannatrek shareholders receive 1.835806 new LGP shares and 0.727502 new contingent value (CV) shares for…
SYDNEY — Bioxyne Ltd. said Monday it has received about £850,000 ($1.7 million AUD) in funding commitments from South of Scotland Enterprise to establish a medicinal cannabis manufacturing and distribution facility in the Scottish Borders. The package includes a five-year £500,000 loan and a grant of £348,250 to support the fit-out of the site,…
SYDNEY, AUSTRALIA: Zelira Therapeutics Ltd (ASX:ZLD) has executed a binding scheme implementation deed to acquire 100% of Health House International Limited (ASX: HHI) via a scheme of arrangement. Zelira believes that the addition of the Health House business will create an organisation with strong medicinal cannabis product and distribution capabilities. The acquisition will see…
SYDNEY, AUSTRALIA: ECS Botanics Holdings has entered into a five year agreement with Polish company Alivio Spolka ZO. for the supply of medicinal cannabis products, which will generate a minimum of $4.5m in revenue for the company. Managing Director, Alex Keach said: “We are very excited to partner with Alivio Spolka. This agreement highlights…
LONDON: Kanabo Group (LON: KNB) has signed a production and supply agreement with PharmaCann Polska under which PharmaCann will supply cartridges containing Kanabo’s proprietary medicinal cannabis formulations for its VapePod inhalation device. The cartridges will be filled and prepared at PharmaCann’s wholly owned facility in North Macedonia. This is a second key agreement directed…
SYDNEY: Wellfully Limited will engage in collaboration with NSW-based Dolce Cann Global Ltd Pty to develop cannabinoid products using its patented drug delivery system. To this end, the Company has entered into a binding Collaboration Agreement with Dolce, by which parties have agreed to an initial trial period for joint research and development, following…
LONDON: Sativa Group’s wholly owned subsidiary Sativa Cultivation and Extraction Ltd, has been awarded a Controlled Drug licence for cannabis (with THC content of greater than 0.2%) cultivation, production, possession and supply, at its Somerset headquarters, by the UK Home Office. Sativa Group is the UK’s leading quoted CBD wellness and medicinal cannabis Group.…